Manufacturer of Controlled Substances; Notice of Registration, 34041 [E7-11907]

Download as PDF 34041 Federal Register / Vol. 72, No. 118 / Wednesday, June 20, 2007 / Notices The company plans to manufacture for in-house dosage form production and for sales to other dosage form manufacturers. When the company first submitted their application, the company submitted information to DEA that the firm would be manufacturing Oxymorphone for in-house dosage form production and sales to other dosage form manufacturers. Upon further investigation by the DEA it was uncovered that the company would only be producing bulk material for dosage form manufacturers. DEA will grant this registration for the production of bulk manufacturing of Oxymorphone. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Noramco Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Noramco Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed. Dated: June 7, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–11916 Filed 6–19–07; 8:45 am] BILLING CODE 4410–09–P Drug Enforcement Administration rwilkins on PROD1PC63 with NOTICES Manufacturer of Controlled Substances; Notice of Registration Jkt 211001 Lysergic acid diethylamide (LSD) (7315). 4-Methoxyamphetamine (7411) ... Normorphine (9313) ..................... Tetrahydrocannabinols (THC) (7370). Alphamethadol (9605) .................. Amphetamine (1100) .................... Methamphetamine (1105) ............ Cocaine (9041) ............................. Hydromorphone (9150) ................ Benzoylecgonine (9180) ............... Hydrocodone (9193) ..................... Morphine (9300) ........................... Oxycodone (9143) ........................ Meperidine (9230) ........................ Methadone (9250) ........................ Oxymorphone (9652) ................... I I I I I II II II II II II II II II II II The company plans to manufacture the listed controlled substances in bulk to manufacture controlled substance derivatives. These derivatives will be used in diagnostic products created specifically for internal use only. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Orasure Technologies, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Orasure Technologies, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. BILLING CODE 4410–09–P 63021–4500, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule I: Drug Marihuana (7360) ......................... Tetrahydrocannabinols (7370) ..... Schedule I I The company plans to import the above listed synthetic products for nonclinical laboratory based research only. In reference to drug code 7360 (Marihuana), the company plans to import synthetic cannabidiol. In reference to drug code 7370 (Tetrahydrocannabinols), the company plans to import synthetic THC. No other activity for this drug code is authorized for this registration. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Tocris Cookson, Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Tocris Cookson, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: June 7, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control,Drug Enforcement Administration. [FR Doc. E7–11912 Filed 6–19–07; 8:45 am] BILLING CODE 4410–09–P By Notice dated February 5, 2007, and published in the Federal Register on February 12, 2007, (72 FR 6579), Orasure Technologies, Inc., Lehigh University, Seeley G. Mudd-Building 6, 220 East First Street, Bethlehem, Pennsylvania 18015, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II: 18:25 Jun 19, 2007 Schedule Dated: June 7, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator,Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–11907 Filed 6–19–07; 8:45 am] DEPARTMENT OF JUSTICE VerDate Aug<31>2005 Drug DEPARTMENT OF JUSTICE DEPARTMENT OF LABOR Drug Enforcement Administration Office of the Secretary Importer of Controlled Substances; Notice of Registration By Notice dated March 19, 2007 and published in the Federal Register on March 27, 2007, (72 FR 14297), Tocris Cookson, Inc., 16144 Westwoods Business Park, Ellisville, Missouri PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 Submission for OMB Review: Comment Request June 13, 2007. The Department of Labor (DOL) has submitted the following public information collection request (ICR) to E:\FR\FM\20JNN1.SGM 20JNN1

Agencies

[Federal Register Volume 72, Number 118 (Wednesday, June 20, 2007)]
[Notices]
[Page 34041]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated February 5, 2007, and published in the Federal 
Register on February 12, 2007, (72 FR 6579), Orasure Technologies, 
Inc., Lehigh University, Seeley G. Mudd-Building 6, 220 East First 
Street, Bethlehem, Pennsylvania 18015, made application by renewal to 
the Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed in 
schedule I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide (LSD) (7315)....  I
4-Methoxyamphetamine (7411)................  I
Normorphine (9313).........................  I
Tetrahydrocannabinols (THC) (7370).........  I
Alphamethadol (9605).......................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Cocaine (9041).............................  II
Hydromorphone (9150).......................  II
Benzoylecgonine (9180).....................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Oxycodone (9143)...........................  II
Meperidine (9230)..........................  II
Methadone (9250)...........................  II
Oxymorphone (9652).........................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk to manufacture controlled substance derivatives. These 
derivatives will be used in diagnostic products created specifically 
for internal use only.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Orasure Technologies, Inc. to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Orasure Technologies, Inc. to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

     Dated: June 7, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator,Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-11907 Filed 6-19-07; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.